Issue Coping With COVID-19 | Pharma's Almanac

Current Issue: Q2 2020

The Next-Generation Issue

Coping With COVID-19

Our second quarter edition spans trending topics across pharma, with a focus on industry responses to the COVID-19 pandemic, including the development and manufacturing of new therapies and vaccines to address COVID-19 and ways to maintain and optimize supply chains and clinical trials.

Also In This Issue

COVID-19

Rethinking Pharma’s Responsibilities in a Time of Crisis

Establishing a sustainable pharmaceutical supply chain is essential to fulfilling the mandate of the industry — this includes the delivery of crucial medicines to patients in a manner that meets their needs while fulfilling the demands of the marketplace. Pandemic Places the Pharma Industry in the Limelight The COVID-19 pandemic has brought the pharmaceutical industry […]

Industry Leader Insight

Accelerating COVID-19 Programs with Comprehensive Support from Cell Line to Commercial Production at a Single Site

INDUSTRY LEADER INSIGHT: Avid Bioservices Pharma/biotech companies developing therapeutic and vaccine candidates to combat SARS-CoV-2 should partner with a CDMO that has experience in the process development and manufacture of traditional and novel biologics and can support projects from concept to launch. At its single site in California, Avid Bioservices has the expertise and capabilities […]

Chronokines

Delivering Breakthrough Medicines for Rare Hematologic Diseases and Cancers

FORMA Therapeutics recently completed its transformation from a research organization to an integrated biopharma company and is advancing exciting candidates through the clinic. Emilie Branch, Managing Editor at Pharma’s Almanac, sat down with FORMA Therapeutics CEO Frank D. Lee to discuss this transformation and the innovative compounds in the FORMA pipeline. Transforming from an Early Discovery […]

Secure Validated Shipping

The Essentiality of Transportation to the Pharma Industry

Boyle Transportation, through its strategic, collaborative logistics and transportation services, is helping pharmaceutical companies get life-saving medicines to people in need despite the challenges posed by the COVID-19 crisis. Transportation in a Time of Crisis Aside from healthcare workers, one sector that tops the list of truly “essential” services during the present pandemic is transportation. […]

Fill-Finish Services

Avara Liscate: High Standards and Expertise in Sterile Manufacturing

Avara Pharmaceutical Services’ Liscate sterile manufacturing facility completed several successful regulatory inspections in 2019. We continue to build on our high standards and extensive expertise to deliver high-quality products on time and in full. A Flexible and Reliable CMO Experience Avara Pharmaceutical Services is a contract manufacturing organization (CMO) whose goal is to provide an […]

CDMO

Positioning a CDMO to Meet Future Needs

The pharmaceutical industry is experiencing significant changes, and many drug companies are looking to re-establish domestic supply chains utilizing U.S.-based CDMOs. Albemarle Fine Chemistry Services (FCS) has a domestic footprint, an impeccable regulatory record, and a successful history of collaboration, and is continuously enhancing its robust development and manufacturing capabilities. Operating in a New World […]

Equipment

Common Challenges and Solutions of Equipment Ownership and Use

There are many factors to consider when tasked with acquiring the equipment needed to run a pharmaceutical facility. Being aware of every upfront costs is a must when determining optimal equipment ownership. A crucial concern when operating any business, and a driver behind purchase decisions, is minimizing overhead to increase profit margins. All variables, including […]

Microbiome

Selecting a Microbiome CDMO Partner for the Long Term

As more microbiome-based therapies progress through the clinic toward approval for market launch, concerns over the lack of outsourcing capacity for process development and commercial manufacturing of live biotherapeutic products are increasing. Arranta Bio is investing heavily in both its process development and cGMP manufacturing capabilities for the supply of clinical trial material and in […]

Integration

Creating Value through Best Practices Across a Global, Integrated Service Provider

The COVID-19 pandemic has highlighted the need for modifications to the pharmaceutical supply chain. SK pharmteco is a global CDMO with integrated service offerings across the development spectrum in Asia, Europe, and the United States. An underpinning commitment to safety and quality, combined with core competencies in several specialized technologies that support the process development […]

Past Issues

View all Past Issues

Innovative & Expert Partners

View Issue »

Issue #2 | Volume #2 | Q2 2016

The Executive Issue

View Issue »

Issue #1 | Volume #6 | Q1 2020

Innovative & Expert Partners

View Issue »

Issue #2 | Volume #3 | Q2 2017

The Role of Innovative Technologies

View Issue »

Issue #4 | Volume #3 | Q4 2017